RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New RSV shot tested for easier storage and use
⭐️ VACCINE ⭐️ CompletedThis study tested the safety and immune response of an RSV vaccine packaged in multidose vials, which are easier to store and transport. It compared the multidose version, which contains a preservative, to the standard single-dose version without a preservative. The trial involve…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 02, 2026 02:26 UTC
-
Nursing home RSV vaccine study: does living situation affect protection?
⭐️ VACCINE ⭐️ CompletedThis study compared how well two already-approved RSV vaccines work in adults over 60. Researchers wanted to see if people living in nursing homes had a similar immune response to the vaccines as people of the same age living independently in the community. All 152 participants r…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE4 • Sponsor: University of Rochester • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:12 UTC
-
One visit, two shots? study tests combo vaccines for older adults
⭐️ VACCINE ⭐️ CompletedThis study tested whether it's safe and effective to give a new RSV vaccine and the existing shingles vaccine at the same time. It involved over 500 healthy adults aged 50 and older. Researchers compared the body's immune response and any side effects when the vaccines were given…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:33 UTC